EMJ

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leman, P
Right arrow Articles by Mukherjee, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leman, P
Right arrow Articles by Mukherjee, D
Emerg Med J 2005; 22:342-346
© 2005 BMJ Publishing Group Ltd, and British Association for Accident and Emergency Medicine


ORIGINAL ARTICLE

Flucloxacillin alone or combined with benzylpenicillin to treat lower limb cellulitis: a randomised controlled trial

P Leman, D Mukherjee

Emergency Department, St Thomas’ Hospital, London, UK

Correspondence to:
Correspondence to:
Dr P Leman
Emergency Department, Royal Perth Hospital, Wellington Street, Perth, WA 6001, Australia; peter.leman{at}health.wa.gov.au

Objective: To determine whether using intravenous benzylpenicillin in addition to intravenous flucloxacillin would result in a more rapid clinical response in patients with lower limb cellulitis.

Methods: This was a randomised controlled trial set in an inner city teaching hospital, comprising 81 patients with lower limb cellulitis requiring intravenous antibiotics. The main outcome measure was the mean number of doses of antibiotic required until clinical response.

Results: The mean number of doses required was 8.47 (95% confidence interval (CI) 7.09 to 9.86) in the benzylpenicillin and flucloxacillin combined group. In the flucloxacillin only group it was 8.71 doses (95% CI 6.90 to 10.5), a mean difference of –0.24 doses (95% CI –2.48 to 2.01, p = 0.83). Other markers of treatment efficacy showed no difference between groups at review the following day; temperature decrease (mean difference –0.07°C, 95% CI –0.76 to 0.62, p = 0.84), or diameter decrease of affected area (mean difference –34 mm, 95% CI –99 to 31, p = 0.30). Patient subjective assessments were also similar between the different drug regimen; improvement on a visual analogue scale of pain/discomfort from admission to first review (mean difference 10 mm, 95% CI –12.6 to 14.2, p = 0.91) and on second review (mean difference 15 mm, 95% CI –18.6 to 21.6, p = 0.88). Patient overall subjective feelings of improvement on first review (p = 0.32) and on second review (p = 0.64) were also similar.

Conclusions: This study provides no evidence to support the addition of intravenous benzylpenicillin to intravenous flucloxacillin in the treatment of lower limb cellulitis.


Abbreviations: ED, emergency department; VAS, visual analogue scale

Keywords: antibiotic therapy; cellulitis; observation medicine







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
© 2005 BMJ Publishing Group Ltd, and British Association for Accident and Emergency Medicine